|  Help  |  About  |  Contact Us

Publication : NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies.

First Author  Zhao JL Year  2011
Journal  Proc Natl Acad Sci U S A Volume  108
Issue  22 Pages  9184-9
PubMed ID  21576471 Mgi Jnum  J:173230
Mgi Id  MGI:5013656 Doi  10.1073/pnas.1105398108
Citation  Zhao JL, et al. (2011) NF-{kappa}B dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A 108(22):9184-9
abstractText  MicroRNA miR-146a has been implicated as a negative feedback regulator of NF-kappaB activation. Knockout of the miR-146a gene in C57BL/6 mice leads to histologically and immunophenotypically defined myeloid sarcomas and some lymphomas. The sarcomas are transplantable to immunologically compromised hosts, showing that they are true malignancies. The animals also exhibit chronic myeloproliferation in their bone marrow. Spleen and marrow cells show increased transcription of NF-kappaB-regulated genes and tumors have higher nuclear p65. Genetic ablation of NF-kappaB p50 suppresses the myeloproliferation, showing that dysregulation of NF-kappaB is responsible for the myeloproliferative disease.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

0 Expression